Additional 500K received from institutional investor to advance PRP towards human trials. This is moving forward, and 2016 looks to be the hinge year for ppch to initiate human trials which will be nothing less than huge. Money says it all---and they have onhand now over 1.2MLL enough to finance through the year....Read the press release.
(0)
(0)
Propanc Biopharma, Inc. (PPCB) Stock Research Links